Stock Traders Purchase Large Volume of UiPath Call Options (NYSE:PATH)

Key Points

• UiPath experienced a significant surge in options trading, with 268,251 call options purchased, marking an increase of approximately 872% compared to the average.
• Research analysts have mixed ratings for UiPath, with a consensus of "Hold" and an average price target of $13.21, while some upgrades moved it to a "strong-buy" rating.
• Insider trading activity was notable, with CEO Daniel Dines and insider Brad Brubaker selling a combined total of over $2.7 million in UiPath shares recently.

UiPath, Inc. (NYSE:PATH - Get Free Report) saw unusually large options trading on Tuesday. Traders acquired 268,251 call options on the company. This is an increase of approximately 872% compared to the typical volume of 27,594 call options.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Cowen reaffirmed a "hold" rating on shares of UiPath in a research note on Friday, September 5th. Truist Financial dropped their price target on UiPath from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, September 5th. Canaccord Genuity Group dropped their price target on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a research note on Monday, September 8th. Zacks Research raised UiPath from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 8th. Finally, DA Davidson assumed coverage on UiPath in a research note on Friday, September 5th. They issued a "neutral" rating and a $12.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $13.21.

UiPath Trading Up 12.5%

Shares of NYSE PATH opened at $14.51 on Tuesday. The company has a market cap of $7.71 billion, a price-to-earnings ratio of 483.67, a PEG ratio of 4.77 and a beta of 1.07. UiPath has a 12 month low of $9.38 and a 12 month high of $15.93. The stock has a 50-day moving average price of $11.61 and a two-hundred day moving average price of $11.89.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. The firm had revenue of $361.73 million during the quarter, compared to the consensus estimate of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The business's quarterly revenue was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, sell-side analysts predict that UiPath will post -0.17 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Brad Brubaker sold 66,665 shares of UiPath stock in a transaction on Monday, October 6th. The stock was sold at an average price of $15.00, for a total transaction of $999,975.00. Following the completion of the sale, the insider owned 690,519 shares of the company's stock, valued at approximately $10,357,785. This trade represents a 8.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Daniel Dines sold 122,733 shares of UiPath stock in a transaction on Monday, October 6th. The stock was sold at an average price of $14.24, for a total value of $1,747,717.92. Following the sale, the chief executive officer directly owned 981,871 shares of the company's stock, valued at $13,981,843.04. This represents a 11.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,614,600 shares of company stock valued at $20,384,459 in the last three months. Insiders own 23.19% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Twin Peaks Wealth Advisors LLC acquired a new position in shares of UiPath in the second quarter valued at approximately $28,000. AdvisorNet Financial Inc increased its stake in shares of UiPath by 320.4% in the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after buying an additional 1,887 shares during the period. CX Institutional acquired a new position in shares of UiPath in the first quarter valued at approximately $36,000. GAMMA Investing LLC increased its stake in shares of UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock valued at $38,000 after buying an additional 969 shares during the period. Finally, IFP Advisors Inc increased its stake in shares of UiPath by 508.0% in the second quarter. IFP Advisors Inc now owns 3,283 shares of the company's stock valued at $42,000 after buying an additional 2,743 shares during the period. Institutional investors and hedge funds own 62.50% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.